Skip to content

Clinical trials

Phase 4 Attention Deficit Disorder with Hyperactivity trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Attention Deficit Disorder with Hyperactivity Phase: Phase 4 Country / region: Canada Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20052
20061
20101
20121
20132
20151
20181
20192
20201
20211
20231
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Unknown status5
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company3
JPM van Stralen Medicine Professional3
Acadia University1
Centre for Anxiety, Attention Deficit and Trauma, Ontario, Canada1
Daniel Coury1
Dar Clinical Research Inc.1
Dr. Martin A. Katzman1
McGill University1
McGill University Health Centre/Research Institute of the McGill University Health Centre1
McMaster University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Attention Deficit Disorder with Hyperactivity17
Anxiety Disorders3
Autism Spectrum Disorder2
Agoraphobia1
Autistic Disorder1
Depressive Disorder1
Generalized Anxiety Disorder1
Panic Disorder1
Phobia, Social1
Sleep Wake Disorders1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.